X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ALKEM LABORATORIES FDC LTD./
ALKEM LABORATORIES
 
P/E (TTM) x 17.5 - - View Chart
P/BV x 3.6 6.1 59.6% View Chart
Dividend Yield % 1.3 0.7 183.3%  

Financials

 FDC LTD.   ALKEM LABORATORIES
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ALKEM LABORATORIES
Mar-16
FDC LTD./
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1441,589 9.0%   
Low Rs791,232 6.4%   
Sales per share (Unadj.) Rs47.6417.5 11.4%  
Earnings per share (Unadj.) Rs7.656.3 13.5%  
Cash flow per share (Unadj.) Rs9.064.7 13.9%  
Dividends per share (Unadj.) Rs2.2512.70 17.7%  
Dividend yield (eoy) %2.00.9 224.6%  
Book value per share (Unadj.) Rs47.5292.9 16.2%  
Shares outstanding (eoy) m177.83119.57 148.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.4 69.2%   
Avg P/E ratio x14.625.1 58.4%  
P/CF ratio (eoy) x12.321.8 56.6%  
Price / Book Value ratio x2.34.8 48.6%  
Dividend payout %29.622.6 131.1%   
Avg Mkt Cap Rs m19,784168,653 11.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2219,171 13.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,45949,915 16.9%  
Other income Rs m3941,645 23.9%   
Total revenues Rs m8,85251,561 17.2%   
Gross profit Rs m2,0708,482 24.4%  
Depreciation Rs m2491,006 24.8%   
Interest Rs m31671 4.6%   
Profit before tax Rs m2,1848,451 25.8%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,606 37.7%   
Profit after tax Rs m1,3536,731 20.1%  
Gross profit margin %24.517.0 144.0%  
Effective tax rate %27.719.0 145.9%   
Net profit margin %16.013.5 118.6%  
BALANCE SHEET DATA
Current assets Rs m4,35527,062 16.1%   
Current liabilities Rs m1,79215,324 11.7%   
Net working cap to sales %30.323.5 128.9%  
Current ratio x2.41.8 137.6%  
Inventory Days Days4467 66.8%  
Debtors Days Days2541 59.8%  
Net fixed assets Rs m3,02512,610 24.0%   
Share capital Rs m179239 74.7%   
"Free" reserves Rs m8,24334,490 23.9%   
Net worth Rs m8,45335,027 24.1%   
Long term debt Rs m111,212 0.9%   
Total assets Rs m10,55754,387 19.4%  
Interest coverage x71.413.6 525.0%   
Debt to equity ratio x00 3.7%  
Sales to assets ratio x0.80.9 87.3%   
Return on assets %13.113.6 96.3%  
Return on equity %16.019.2 83.3%  
Return on capital %23.524.9 94.6%  
Exports to sales %13.312.9 102.8%   
Imports to sales %3.33.1 108.3%   
Exports (fob) Rs m1,1266,461 17.4%   
Imports (cif) Rs m2831,540 18.4%   
Fx inflow Rs m1,1466,563 17.5%   
Fx outflow Rs m3553,012 11.8%   
Net fx Rs m7913,552 22.3%   
CASH FLOW
From Operations Rs m1,4857,259 20.5%  
From Investments Rs m-6201,864 -33.2%  
From Financial Activity Rs m-753-9,273 8.1%  
Net Cashflow Rs m113-150 -75.2%  

Share Holding

Indian Promoters % 68.9 66.9 103.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 33.1 14.2%  
FIIs % 7.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 0.0 -  
Shareholders   23,730 68,381 34.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 18, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - DIVIS LABORATORIES COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS